A recent phase three program showed it improved A1C (a three-month average of blood sugar) more than comparators [the drugs it was tested against] and led to significant weight loss, with side effects mostly in the digestive tract (nausea, vomiting [and] diarrhea), like other GLP-1 drugs. Wegovy pill Orforglipron isnt the only pill-form GLP-1 generating excitement
Like tesamorelin, it works by stimulating the pituitary gland to release more endogenous growth hormone
The future of metabolic healthcare will be defined not only by stronger molecules, but by stronger evidence-to-market frameworks
I have patients who have been doing extremely well on the medications and all of a sudden, insurance decides to not cover the medication anymore for whatever reason, says Dr
One of the included studies indicated that ESP exerted anti-RA effects by increasing SCFA levels such as butyrate, which in turn enhanced intestinal barrier integrity (upregulating ZO-1 expression, repairing intestinal mucosal damage) (19)